Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Ntrk3em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Ntrk3em1flox/Cya

Common Name
Ntrk3-flox
Product ID
S-CKO-04046
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-18213-Ntrk3-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Ntrk3-flox Mouse (Catalog S-CKO-04046) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Ntrk3-flox
Strain ID
CKOCMP-18213-Ntrk3-B6J-VA
Gene Name
Ntrk3
Product ID
S-CKO-04046
Gene Alias
TrkC, Ntrk3_tv3
Background
C57BL/6JCya
Gene Full Name
neurotrophic tyrosine kinase, receptor, type 3
Modification
Conditional knockout
NCBI ID
18213 (Mouse)
Phenotype
MGI:97385
Chromosome
Chr 7 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000039431
NCBI Transcript ID
NM_008746
Target Region
Exon 5
Size of Effective Region
~2.5 kb
Overview of Gene Research
Ntrk3, also known as the neurotrophin-3 receptor, encodes a protein tyrosine kinase. It is involved in multiple signaling cascades, such as the Ras-MAP kinase and PI3K-AKT pathways through the IRS-1 adapter protein [4]. Ntrk3 has pleiotropic functions, acting as an oncogene in some cancers like breast and gastric cancers, and as a dependence receptor in tumor suppressor genes in colon cancer and neuroblastomas [6]. It also plays a role in the regulation of gonadotrope cell adhesion and motility through the Neurod1/4-Ntrk3-cSrc pathway [8].

Ntrk3 gene fusions are oncogenic drivers in various cancers. The ETV6-Ntrk3 (TEL-TRKC) gene fusion, associated with congenital fibrosarcoma, encodes a chimeric oncoprotein with transformation activity in multiple cell lineages [4]. In breast, salivary gland (secretory carcinomas), prostatic acinar adenocarcinoma, and ganglioglioma, Ntrk3 gene fusions have been identified as drivers or rare molecular events [1,2,3,5]. In upper tract urothelial carcinomas, higher Ntrk3 expression is correlated with worse survival outcomes, and it may interact with the PI3K-AKT-mTOR signaling pathway to promote cancer [6]. In Spitz tumours, Ntrk3 fusions expand the range of oncogenic kinase fusions in melanocytic neoplasms [7].

In conclusion, Ntrk3 is crucial in multiple biological processes and is significantly involved in various disease conditions, especially cancer. The discovery of Ntrk3 gene fusions in different cancers highlights its importance as a potential therapeutic target. Understanding Ntrk3's role through gene-based research models helps in developing more targeted treatment strategies for these cancers.

References:
1. Whaley, Rumeal D, Tekin, Burak, McCarthy, Michael R, Cheville, John C, Gupta, Sounak. 2024. NTRK3-Rearranged Prostatic Acinar Adenocarcinoma: Report of a Patient and Review of the Literature. In International journal of surgical pathology, 33, 204-208. doi:10.1177/10668969241253197. https://pubmed.ncbi.nlm.nih.gov/38772598/
2. Mortensen, Lindsey, Ordulu, Zehra, Dagogo-Jack, Ibiayi, Bardia, Aditya, Spring, Laura M. 2021. Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion. In The oncologist, 26, 818-824. doi:10.1002/onco.13880. https://pubmed.ncbi.nlm.nih.gov/34176200/
3. Rubino, Sebastian, Lynes, John, McBride, Paul, Macaulay, Robert, Vogelbaum, Michael A. 2022. NTRK3 gene fusion in an adult ganglioglioma: illustrative case. In Journal of neurosurgery. Case lessons, 3, . doi:10.3171/CASE21645. https://pubmed.ncbi.nlm.nih.gov/36130567/
4. Lannon, Chris L, Sorensen, Poul H B. . ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. In Seminars in cancer biology, 15, 215-23. doi:. https://pubmed.ncbi.nlm.nih.gov/15826836/
5. Cardoni, Antonello, De Vito, Rita, Milano, Giuseppe Maria, De Pasquale, Maria Debora, Alaggio, Rita. 2022. A Pediatric Case of High-Grade Secretory Carcinoma of the Maxillary Sinus With ETV6::NTRK3 Gene Fusion, Therapeutic Implications, and Review of the Literature. In Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 26, 59-64. doi:10.1177/10935266221138706. https://pubmed.ncbi.nlm.nih.gov/36448441/
6. Lim, Lee-Moay, Lee, Yi-Chen, Lin, Ting-Wei, Kuo, Hung-Tien, Huang, A-Mei. 2024. NTRK3 exhibits a pro-oncogenic function in upper tract urothelial carcinomas. In The Kaohsiung journal of medical sciences, 40, 445-455. doi:10.1002/kjm2.12824. https://pubmed.ncbi.nlm.nih.gov/38593276/
7. Yeh, Iwei, Tee, Meng Kian, Botton, Thomas, LeBoit, Philip E, Bastian, Boris C. . NTRK3 kinase fusions in Spitz tumours. In The Journal of pathology, 240, 282-290. doi:10.1002/path.4775. https://pubmed.ncbi.nlm.nih.gov/27477320/
8. Le Ciclé, Charles, Pacini, Vincent, Rama, Nicolas, Cohen-Tannoudji, Joëlle, L'hôte, David. 2023. The Neurod1/4-Ntrk3-Src pathway regulates gonadotrope cell adhesion and motility. In Cell death discovery, 9, 327. doi:10.1038/s41420-023-01615-7. https://pubmed.ncbi.nlm.nih.gov/37658038/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research